Clinical Trial Update: A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating atezolizumab with carboplatin and etoposide for untreated extensive-stage small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Small Cell Lung Carcinoma | Phase 3 | Status: COMPLETED